Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,209.28 +37.13 (+0.45%) Bitcoin USD
59,195.99 +672.73 (+1.15%) CMC Crypto 200
1,280.13 +3.15 (+0.25%)
AMGN Jan 2026 195.000 put
| Previous close | 8.45 |
| Open | 8.45 |
| Bid | 9.40 |
| Ask | 10.20 |
| Strike | 195.00 |
| Expiry date | 2026-01-16 |
| Day's range | 8.45 - 8.45 |
| Contract range | N/A |
| Volume | |
| Open interest | 829 |
- Yahoo Finance Video
Amgen, DraftKings, Live Nation: Trending tickers
Shares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations. The biotechnology giant's revenue rose by 22% during the quarter. DraftKings (DKNG) also delivered a strong earnings report, surpassing analysts' estimates on both the top and bottom lines. Buoyed by this performance, the company raised its full-year outlook. Live Nation (LYV) topped revenue estimates in its first quarter earnings, although the company reported a loss of $0.53 per share. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith
Barrons.comAmgen Stock Jumps on Obesity Drug Optimism. What Comes Next.
The company is trying to carve a niche in a rapidly growing obesity-drug market that’s currently dominated by Eli Lilly and Novo Nordisk.
Barrons.comThese Stocks Are Moving the Most Today: Apple, Amgen, Expedia, Block, Coinbase, Cloudflare, Fortinet, and More
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
